Skip to main content

Year: 2021

Plastic Straps Market to reach USD 7.49 Billion by 2030 with an astounding CAGR of 16.40% – Report by Market Research Future (MRFR)

New York, Dec. 14, 2021 (GLOBE NEWSWIRE) — Plastic Straps Market Overview: According to a comprehensive research report by Market Research Future (MRFR), “Plastic Straps Market Research by Type (Polyester Straps, Polypropylene Straps, Nylon Straps, and Others), by End-Use (Steel, Cotton, Paper, Fiber, Bricks & Tiles and Others) and  Region – Forecast to 2030”, the market is eyeing for a doubling of its present valuation set at USD 2.4 Billion (2021) and is expected to reach USD 7.49 Billion by 2030 with an astounding CAGR of 16.40% during the forecast period (2022-2030). List of the companies profiled in the global Plastic Straps Market research report are –Crown Holdings (US) Teufelberger (Austria) Polychem Corporation (US) FROMM Packaging (US) Dubose Strapping (US) Messersi Packaging (Italy) Auto Strap (India) Polychem...

Continue reading

Taaleri launches a private equity fund focusing on bioindustry – the fund is classified as dark green as it only makes sustainable investments

TAALERI PLC                        PRESS RELEASE         14 DECEMBER 2021 AT 9:15 (EET) Taaleri launches a private equity fund focusing on bioindustry – the fund is classified as dark green as it only makes sustainable investments The investment and asset manager Taaleri launches Taaleri Bioindustry I fund, which focuses on bioindustry. This is Europe’s first private equity fund to focus purely on bioindustry projects. It is also one of Finland’s first private equity funds to be classified as dark green, i.e. funds under Article 9 of the EU’s Sustainable Finance Disclosure Regulation. The fund only makes sustainable investments in projects that, for example, contribute substantially to climate change mitigation. The fund also reports extensively on the sustainability impact of its investments. Taaleri Bioindustry I will invest...

Continue reading

TCM Group A/S: Financial calendar 2022

COMPANY ANNOUNCEMENT                                                                                                                     No. 119/2021 Tvis, 14 December 2021 Financial calendar 2022The Board of Directors of TCM Group A/S has set the following dates for publication of the interim reports, annual reports and annual general meeting: 25 February 2022        Interim report Q4 2021 and Annual report 20211 March 2022              Deadline for submission of shareholder proposals to Annual General Meeting5 April 2022                Annual General Meeting18 May 2022               Interim report Q1 202219 August 2022           Interim report Q2 202215 November 2022      Interim report Q3 202224 February 2023        Interim report Q4 2022 and Annual report 202213 April 2023              Annual General Meeting The annual report and the...

Continue reading

UPS Surpasses One Billion Covid-19 Vaccine Delivery Milestone, Continues To Deliver Hope Around The World

COVID-19 vaccines delivered with 99.9 percent on-time performance to more than 110 countries to support the ongoing fight against the global pandemic ATLANTA, Dec. 14, 2021 (GLOBE NEWSWIRE) — UPS (NYSE: UPS) today announced that it surpassed the one billion COVID-19 vaccine doses delivered mark with near-perfect on-time delivery. Just one year after the first vaccine was delivered by UPS, this milestone was made possible through UPS’s innovative approaches, one-of-a-kind UPS® Premier tracking technologies, industry-leading cold chain solutions, and an expansive, sophisticated, global network providing UPS Healthcare™ services to customers and communities around the world. “UPSers have been essential in the fight against COVID-19, delivering equitable access to critical healthcare services’” said Chief Sales and Solutions Officer...

Continue reading

OKYO Pharma announces issuance of U.S. Patent No. 11,197,906 covering OKYO Pharma’s drug candidate OK-101 for use to treat dry eye disease

LONDON and BOSTON, Dec. 14, 2021 (GLOBE NEWSWIRE) — OKYO Pharma Limited (LSE: OKYO; OTCQB: EMMLF), a biotechnology company focused on the discovery and development of novel molecules to treat inflammatory dry eye diseases and ocular pain, today announced that the patent entitled “Methods of Lowering Blink Reflex for the Treatment of Dry Eye Disease” has been issued by the United States Patent and Trademark Office (“USPTO”) as U.S. Patent No. 11,197,906. This patent contains key claims covering OK-101 to treat dry eye disease. OK-101 is OKYO’s lead pre-clinical compound and is a novel long-acting GPCR-based anti-inflammatory drug candidate. The work recited in this patent lays out the potential of OK-101, a lipidated chemerin analogue, to treat patients with dry eye disease (“DED”). The drug, planned to be administered...

Continue reading

GXO Achieves Industry First with Multi-Tiered Collaborative Mobile Robot

New automation technology brings higher productivity to existing site NORTHAMPTON, U.K., , Dec. 14, 2021 (GLOBE NEWSWIRE) — GXO Logistics, Inc. (NYSE: GXO), the world’s largest pure-play contract logistics provider, announced today that it has achieved an industry first by deploying 6 River Systems (6RS) collaborative robots, or cobots, on multiple mezzanine floors in one of its distribution centers in Milton Keynes, England. “This multi-tiered installation is groundbreaking for us and a first in our industry,” said Gavin Williams, Managing Director, GXO UK and Ireland. “The solution illustrates our significant investment in technology that helps us improve productivity for our customers and safety for our colleagues while optimizing vertical warehouse space in Europe.”  GXO collaborated with 6RS to develop and test new features...

Continue reading

Philips to further expand its image-guided therapy devices portfolio through acquisition of Vesper Medical

Philips intravascular ultrasound (IVUS) imagingVesper DUO Venous Stent SystemDecember 14, 2021 Amsterdam, the Netherlands – Royal Philips (NYSE: PHG; AEX: PHIA), a global leader in health technology, today announced that it has signed an agreement to acquire Vesper Medical Inc., a US-based medical technology company that develops minimally-invasive peripheral vascular devices. Vesper Medical will further expand Philips’ portfolio of diagnostic and therapeutic devices with an advanced venous stent portfolio for the treatment of deep venous disease. The transaction, which is subject to customary closing conditions, is expected to be completed in the first quarter of 2022. Financial details of the transaction were not disclosed. Philips already has a leading peripheral vascular portfolio, consisting of: live...

Continue reading

With Stunning 26.2% CAGR, Alternative Fuel Vehicles Market Size [2021-2028] | to Reach USD 1,681.80 Billion

Key Prominent Players Covered in the Alternative Fuel Vehicles Market are Honda Motor Co., Ltd. (Tokyo, Japan), Toyota Motor Corporation (Aichi, Japan), Nissan Motor Corporation (Yokohama, Kanagawa, Japan), Daimler AG (Stuttgart, Germany), Tesla (California, U.S.), BYD Company Ltd. (Shenzhen, China), Ford Motor Company (Michigan, U.S.), MITSUBISHI MOTORS CORPORATION. (Tokyo, Japan), SHELL International B.V. (Hague, Netherlands), JAGUAR LAND ROVER AUTOMOTIVE PLC (Coventry, U.K.) and Others Pune, India, Dec. 14, 2021 (GLOBE NEWSWIRE) — The global alternative fuel vehicles market size was USD 293.45 billion in 2020. The market is projected to grow from USD 330.45 billion in 2021 to USD 1,681.80 billion by 2028, exhibiting a Compound Annual Growth Rate (CAGR) of 26.2% during the forecast period. This information is published by Fortune...

Continue reading

VGP NV: Enters the French Market and Announces the Appointment of Aurélien Coudert as Country Manager VGP France

PRESS RELEASERegulated InformationAntwerp/Belgium – Lyon/France, 14 December 2021, 07:30 am CET – VGP, a pan-European provider of high-quality logistics and semi-industrial real estate, officially enters the French market with the opening of its first office in Lyon and appoints Aurélien Coudert as Country Manager for VGP France. Aurélien started on 1 December within the VGP team and will be responsible for the expansion of the Group’s portfolio in the French market. In the coming period the focus will be on identifying suitable development locations. Aurélien Coudert comments: “I am excited by the challenge of launching the VGP business unit in France and to work in such a dynamic and ambitious company. I’m impressed by VGP’s family and European culture, its long-term vision but also the agile organisation. With the logistics and industrial...

Continue reading

At Stunning 12.6% CAGR, Bovine Lactoferrin Market Size 2021-2028 | To Reach USD 1,461.3 Million

Key Companies in Bovine Lactoferrin Market are MILEI GmbH, FrieslandCampina DOMO, Synlait Ltd., Glanbia Plc., Bega Bionutrients, Saputo Dairy Australia Pty Ltd., Fonterra Co-operative Group, FREEDOM FOODS GROUP LIMITED, Beston Global Food Company Ltd, Armor Protéines, Ingredia Pune, India, Dec. 14, 2021 (GLOBE NEWSWIRE) — The global bovine lactoferrin market is set to gain traction from its rising applications in pharmaceutical, food & beverage, and dietary supplements. Nowadays, the general population is highly demanding for naturally derived supplements, rather than the ones containing chemical molecules. It is set to propel the demand for bovine lactoferrin across the globe. As per a report by Fortune Business Insights™, titled, “Bovine Lactoferrin Market, 2021-2028,” the market size stood at USD 601.1 million in 2020....

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.